nodes	percent_of_prediction	percent_of_DWPC	metapath
Maraviroc—CYP3A4—Ticagrelor—coronary artery disease	0.0656	0.146	CbGbCtD
Maraviroc—CYP3A4—Fenofibrate—coronary artery disease	0.0585	0.13	CbGbCtD
Maraviroc—CYP3A4—Gemfibrozil—coronary artery disease	0.0468	0.104	CbGbCtD
Maraviroc—CYP3A4—Clopidogrel—coronary artery disease	0.0405	0.0904	CbGbCtD
Maraviroc—CYP3A4—Eplerenone—coronary artery disease	0.0377	0.0841	CbGbCtD
Maraviroc—CYP3A4—Enalapril—coronary artery disease	0.0336	0.0749	CbGbCtD
Maraviroc—CYP3A4—Rosuvastatin—coronary artery disease	0.0261	0.0583	CbGbCtD
Maraviroc—CYP3A4—Ezetimibe—coronary artery disease	0.0261	0.0583	CbGbCtD
Maraviroc—CYP3A4—Simvastatin—coronary artery disease	0.0243	0.0542	CbGbCtD
Maraviroc—CYP3A4—Pravastatin—coronary artery disease	0.0238	0.053	CbGbCtD
Maraviroc—CYP3A4—Lovastatin—coronary artery disease	0.0238	0.053	CbGbCtD
Maraviroc—CYP3A4—Atorvastatin—coronary artery disease	0.0216	0.0483	CbGbCtD
Maraviroc—CYP3A4—Losartan—coronary artery disease	0.0198	0.0442	CbGbCtD
Maraviroc—CCR5—heart—coronary artery disease	0.00224	0.362	CbGeAlD
Maraviroc—CCR5—cardiovascular system—coronary artery disease	0.00211	0.341	CbGeAlD
Maraviroc—CCR5—blood—coronary artery disease	0.00167	0.27	CbGeAlD
Maraviroc—CYP3A4—blood—coronary artery disease	0.000168	0.0272	CbGeAlD
Maraviroc—Diarrhoea—Simvastatin—coronary artery disease	8.78e-05	0.000253	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Furosemide—coronary artery disease	8.77e-05	0.000253	CcSEcCtD
Maraviroc—Myalgia—Ramipril—coronary artery disease	8.77e-05	0.000253	CcSEcCtD
Maraviroc—Fatigue—Furosemide—coronary artery disease	8.76e-05	0.000252	CcSEcCtD
Maraviroc—Tremor—Lisinopril—coronary artery disease	8.75e-05	0.000252	CcSEcCtD
Maraviroc—Abdominal pain—Telmisartan—coronary artery disease	8.75e-05	0.000252	CcSEcCtD
Maraviroc—Body temperature increased—Telmisartan—coronary artery disease	8.75e-05	0.000252	CcSEcCtD
Maraviroc—Anxiety—Ramipril—coronary artery disease	8.74e-05	0.000252	CcSEcCtD
Maraviroc—Vomiting—Lovastatin—coronary artery disease	8.73e-05	0.000251	CcSEcCtD
Maraviroc—Dizziness—Eplerenone—coronary artery disease	8.71e-05	0.000251	CcSEcCtD
Maraviroc—Rash—Clopidogrel—coronary artery disease	8.71e-05	0.000251	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	8.71e-05	0.000251	CcSEcCtD
Maraviroc—Dermatitis—Clopidogrel—coronary artery disease	8.7e-05	0.000251	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—FGB—coronary artery disease	8.7e-05	0.000439	CbGpPWpGaD
Maraviroc—Asthenia—Valsartan—coronary artery disease	8.7e-05	0.00025	CcSEcCtD
Maraviroc—Pain—Furosemide—coronary artery disease	8.69e-05	0.00025	CcSEcCtD
Maraviroc—Constipation—Furosemide—coronary artery disease	8.69e-05	0.00025	CcSEcCtD
Maraviroc—Hypersensitivity—Niacin—coronary artery disease	8.68e-05	0.00025	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—HTR2A—coronary artery disease	8.68e-05	0.000438	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—C3—coronary artery disease	8.67e-05	0.000437	CbGpPWpGaD
Maraviroc—Discomfort—Ramipril—coronary artery disease	8.66e-05	0.000249	CcSEcCtD
Maraviroc—Asthenia—Olmesartan—coronary artery disease	8.66e-05	0.000249	CcSEcCtD
Maraviroc—Headache—Clopidogrel—coronary artery disease	8.65e-05	0.000249	CcSEcCtD
Maraviroc—Rash—Lovastatin—coronary artery disease	8.65e-05	0.000249	CcSEcCtD
Maraviroc—Dermatitis—Lovastatin—coronary artery disease	8.65e-05	0.000249	CcSEcCtD
Maraviroc—Anaemia—Lisinopril—coronary artery disease	8.63e-05	0.000249	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—EDNRB—coronary artery disease	8.61e-05	0.000434	CbGpPWpGaD
Maraviroc—Headache—Lovastatin—coronary artery disease	8.6e-05	0.000248	CcSEcCtD
Maraviroc—Pruritus—Valsartan—coronary artery disease	8.58e-05	0.000247	CcSEcCtD
Maraviroc—Myalgia—Timolol—coronary artery disease	8.57e-05	0.000247	CcSEcCtD
Maraviroc—Vomiting—Ezetimibe—coronary artery disease	8.56e-05	0.000246	CcSEcCtD
Maraviroc—Hypersensitivity—Pravastatin—coronary artery disease	8.55e-05	0.000246	CcSEcCtD
Maraviroc—Gastrointestinal pain—Perindopril—coronary artery disease	8.55e-05	0.000246	CcSEcCtD
Maraviroc—Anxiety—Timolol—coronary artery disease	8.54e-05	0.000246	CcSEcCtD
Maraviroc—Pruritus—Olmesartan—coronary artery disease	8.54e-05	0.000246	CcSEcCtD
Maraviroc—Decreased appetite—Losartan—coronary artery disease	8.52e-05	0.000245	CcSEcCtD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	8.51e-05	0.000245	CcSEcCtD
Maraviroc—Body temperature increased—Captopril—coronary artery disease	8.51e-05	0.000245	CcSEcCtD
Maraviroc—Abdominal pain—Captopril—coronary artery disease	8.51e-05	0.000245	CcSEcCtD
Maraviroc—CCR5—Disease—APOB—coronary artery disease	8.51e-05	0.000429	CbGpPWpGaD
Maraviroc—Dizziness—Simvastatin—coronary artery disease	8.49e-05	0.000244	CcSEcCtD
Maraviroc—Rash—Ezetimibe—coronary artery disease	8.49e-05	0.000244	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—THBS1—coronary artery disease	8.48e-05	0.000428	CbGpPWpGaD
Maraviroc—Dermatitis—Ezetimibe—coronary artery disease	8.48e-05	0.000244	CcSEcCtD
Maraviroc—Discomfort—Timolol—coronary artery disease	8.47e-05	0.000244	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—SULT1E1—coronary artery disease	8.46e-05	0.000427	CbGpPWpGaD
Maraviroc—Asthenia—Niacin—coronary artery disease	8.46e-05	0.000244	CcSEcCtD
Maraviroc—Fatigue—Losartan—coronary artery disease	8.45e-05	0.000243	CcSEcCtD
Maraviroc—Headache—Ezetimibe—coronary artery disease	8.43e-05	0.000243	CcSEcCtD
Maraviroc—Oedema—Ramipril—coronary artery disease	8.41e-05	0.000242	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PSMB5—coronary artery disease	8.4e-05	0.000424	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PSMA6—coronary artery disease	8.4e-05	0.000424	CbGpPWpGaD
Maraviroc—Constipation—Losartan—coronary artery disease	8.38e-05	0.000241	CcSEcCtD
Maraviroc—Pain—Losartan—coronary artery disease	8.38e-05	0.000241	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—F2—coronary artery disease	8.38e-05	0.000423	CbGpPWpGaD
Maraviroc—Syncope—Lisinopril—coronary artery disease	8.38e-05	0.000241	CcSEcCtD
Maraviroc—Vomiting—Eplerenone—coronary artery disease	8.38e-05	0.000241	CcSEcCtD
Maraviroc—Leukopenia—Lisinopril—coronary artery disease	8.36e-05	0.000241	CcSEcCtD
Maraviroc—Nausea—Fenofibrate—coronary artery disease	8.35e-05	0.00024	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—SULT1E1—coronary artery disease	8.34e-05	0.000421	CbGpPWpGaD
Maraviroc—Pruritus—Niacin—coronary artery disease	8.34e-05	0.00024	CcSEcCtD
Maraviroc—Asthenia—Pravastatin—coronary artery disease	8.33e-05	0.00024	CcSEcCtD
Maraviroc—Gastrointestinal pain—Furosemide—coronary artery disease	8.31e-05	0.000239	CcSEcCtD
Maraviroc—Rash—Eplerenone—coronary artery disease	8.31e-05	0.000239	CcSEcCtD
Maraviroc—Hypersensitivity—Trandolapril—coronary artery disease	8.3e-05	0.000239	CcSEcCtD
Maraviroc—Dermatitis—Eplerenone—coronary artery disease	8.3e-05	0.000239	CcSEcCtD
Maraviroc—Diarrhoea—Valsartan—coronary artery disease	8.29e-05	0.000239	CcSEcCtD
Maraviroc—Shock—Ramipril—coronary artery disease	8.27e-05	0.000238	CcSEcCtD
Maraviroc—Hypersensitivity—Enalapril—coronary artery disease	8.27e-05	0.000238	CcSEcCtD
Maraviroc—Body temperature increased—Perindopril—coronary artery disease	8.26e-05	0.000238	CcSEcCtD
Maraviroc—Abdominal pain—Perindopril—coronary artery disease	8.26e-05	0.000238	CcSEcCtD
Maraviroc—Diarrhoea—Olmesartan—coronary artery disease	8.25e-05	0.000238	CcSEcCtD
Maraviroc—Headache—Eplerenone—coronary artery disease	8.25e-05	0.000238	CcSEcCtD
Maraviroc—Nervous system disorder—Ramipril—coronary artery disease	8.24e-05	0.000237	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—AGT—coronary artery disease	8.24e-05	0.000416	CbGpPWpGaD
Maraviroc—Oedema—Timolol—coronary artery disease	8.22e-05	0.000237	CcSEcCtD
Maraviroc—Pruritus—Pravastatin—coronary artery disease	8.21e-05	0.000236	CcSEcCtD
Maraviroc—Loss of consciousness—Lisinopril—coronary artery disease	8.21e-05	0.000236	CcSEcCtD
Maraviroc—Nausea—Clopidogrel—coronary artery disease	8.21e-05	0.000236	CcSEcCtD
Maraviroc—CCR5—Disease—FGF1—coronary artery disease	8.18e-05	0.000413	CbGpPWpGaD
Maraviroc—Skin disorder—Ramipril—coronary artery disease	8.17e-05	0.000235	CcSEcCtD
Maraviroc—Infection—Timolol—coronary artery disease	8.16e-05	0.000235	CcSEcCtD
Maraviroc—Vomiting—Simvastatin—coronary artery disease	8.16e-05	0.000235	CcSEcCtD
Maraviroc—Hypersensitivity—Telmisartan—coronary artery disease	8.16e-05	0.000235	CcSEcCtD
Maraviroc—Cough—Lisinopril—coronary artery disease	8.15e-05	0.000235	CcSEcCtD
Maraviroc—Nausea—Lovastatin—coronary artery disease	8.15e-05	0.000235	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—EDNRA—coronary artery disease	8.13e-05	0.00041	CbGpPWpGaD
Maraviroc—CCR5—Disease—LPL—coronary artery disease	8.12e-05	0.00041	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ADRB1—coronary artery disease	8.1e-05	0.000408	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CYBA—coronary artery disease	8.1e-05	0.000408	CbGpPWpGaD
Maraviroc—Rash—Simvastatin—coronary artery disease	8.09e-05	0.000233	CcSEcCtD
Maraviroc—Dermatitis—Simvastatin—coronary artery disease	8.09e-05	0.000233	CcSEcCtD
Maraviroc—Asthenia—Trandolapril—coronary artery disease	8.09e-05	0.000233	CcSEcCtD
Maraviroc—Shock—Timolol—coronary artery disease	8.09e-05	0.000233	CcSEcCtD
Maraviroc—Diarrhoea—Niacin—coronary artery disease	8.06e-05	0.000232	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—DUSP6—coronary artery disease	8.06e-05	0.000407	CbGpPWpGaD
Maraviroc—Nervous system disorder—Timolol—coronary artery disease	8.06e-05	0.000232	CcSEcCtD
Maraviroc—Asthenia—Enalapril—coronary artery disease	8.05e-05	0.000232	CcSEcCtD
Maraviroc—Headache—Simvastatin—coronary artery disease	8.04e-05	0.000232	CcSEcCtD
Maraviroc—Body temperature increased—Furosemide—coronary artery disease	8.03e-05	0.000231	CcSEcCtD
Maraviroc—Abdominal pain—Furosemide—coronary artery disease	8.03e-05	0.000231	CcSEcCtD
Maraviroc—Gastrointestinal pain—Losartan—coronary artery disease	8.02e-05	0.000231	CcSEcCtD
Maraviroc—Dizziness—Valsartan—coronary artery disease	8.02e-05	0.000231	CcSEcCtD
Maraviroc—Anorexia—Ramipril—coronary artery disease	8.01e-05	0.000231	CcSEcCtD
Maraviroc—Nausea—Ezetimibe—coronary artery disease	8e-05	0.00023	CcSEcCtD
Maraviroc—Skin disorder—Timolol—coronary artery disease	7.98e-05	0.00023	CcSEcCtD
Maraviroc—Dizziness—Olmesartan—coronary artery disease	7.98e-05	0.00023	CcSEcCtD
Maraviroc—Pruritus—Trandolapril—coronary artery disease	7.97e-05	0.00023	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—AKR1B1—coronary artery disease	7.96e-05	0.000402	CbGpPWpGaD
Maraviroc—Myalgia—Lisinopril—coronary artery disease	7.95e-05	0.000229	CcSEcCtD
Maraviroc—Asthenia—Telmisartan—coronary artery disease	7.94e-05	0.000229	CcSEcCtD
Maraviroc—Pruritus—Enalapril—coronary artery disease	7.94e-05	0.000229	CcSEcCtD
Maraviroc—Diarrhoea—Pravastatin—coronary artery disease	7.94e-05	0.000229	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PLAT—coronary artery disease	7.93e-05	0.0004	CbGpPWpGaD
Maraviroc—Anxiety—Lisinopril—coronary artery disease	7.93e-05	0.000228	CcSEcCtD
Maraviroc—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—coronary artery disease	7.92e-05	0.000399	CbGpPWpGaD
Maraviroc—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	7.9e-05	0.000227	CcSEcCtD
Maraviroc—Discomfort—Lisinopril—coronary artery disease	7.86e-05	0.000226	CcSEcCtD
Maraviroc—Anorexia—Timolol—coronary artery disease	7.83e-05	0.000226	CcSEcCtD
Maraviroc—Pruritus—Telmisartan—coronary artery disease	7.83e-05	0.000226	CcSEcCtD
Maraviroc—Nausea—Eplerenone—coronary artery disease	7.83e-05	0.000225	CcSEcCtD
Maraviroc—Dizziness—Niacin—coronary artery disease	7.79e-05	0.000224	CcSEcCtD
Maraviroc—Abdominal pain—Losartan—coronary artery disease	7.75e-05	0.000223	CcSEcCtD
Maraviroc—Body temperature increased—Losartan—coronary artery disease	7.75e-05	0.000223	CcSEcCtD
Maraviroc—Asthenia—Captopril—coronary artery disease	7.72e-05	0.000222	CcSEcCtD
Maraviroc—Diarrhoea—Trandolapril—coronary artery disease	7.71e-05	0.000222	CcSEcCtD
Maraviroc—Vomiting—Valsartan—coronary artery disease	7.71e-05	0.000222	CcSEcCtD
Maraviroc—Diarrhoea—Enalapril—coronary artery disease	7.68e-05	0.000221	CcSEcCtD
Maraviroc—Dizziness—Pravastatin—coronary artery disease	7.67e-05	0.000221	CcSEcCtD
Maraviroc—Vomiting—Olmesartan—coronary artery disease	7.67e-05	0.000221	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Ramipril—coronary artery disease	7.66e-05	0.000221	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CXCL12—coronary artery disease	7.65e-05	0.000386	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—BDKRB2—coronary artery disease	7.65e-05	0.000386	CbGpPWpGaD
Maraviroc—Rash—Valsartan—coronary artery disease	7.64e-05	0.00022	CcSEcCtD
Maraviroc—Dermatitis—Valsartan—coronary artery disease	7.64e-05	0.00022	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—POMC—coronary artery disease	7.64e-05	0.000385	CbGpPWpGaD
Maraviroc—Nausea—Simvastatin—coronary artery disease	7.62e-05	0.00022	CcSEcCtD
Maraviroc—Oedema—Lisinopril—coronary artery disease	7.62e-05	0.00022	CcSEcCtD
Maraviroc—CCR5—Disease—PPP2CA—coronary artery disease	7.62e-05	0.000384	CbGpPWpGaD
Maraviroc—Pruritus—Captopril—coronary artery disease	7.62e-05	0.000219	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—F2—coronary artery disease	7.61e-05	0.000384	CbGpPWpGaD
Maraviroc—Rash—Olmesartan—coronary artery disease	7.61e-05	0.000219	CcSEcCtD
Maraviroc—Insomnia—Ramipril—coronary artery disease	7.6e-05	0.000219	CcSEcCtD
Maraviroc—Dermatitis—Olmesartan—coronary artery disease	7.6e-05	0.000219	CcSEcCtD
Maraviroc—Headache—Valsartan—coronary artery disease	7.59e-05	0.000219	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL6ST—coronary artery disease	7.58e-05	0.000382	CbGpPWpGaD
Maraviroc—Diarrhoea—Telmisartan—coronary artery disease	7.58e-05	0.000218	CcSEcCtD
Maraviroc—Infection—Lisinopril—coronary artery disease	7.57e-05	0.000218	CcSEcCtD
Maraviroc—Headache—Olmesartan—coronary artery disease	7.56e-05	0.000218	CcSEcCtD
Maraviroc—Paraesthesia—Ramipril—coronary artery disease	7.55e-05	0.000217	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—JUNB—coronary artery disease	7.51e-05	0.000379	CbGpPWpGaD
Maraviroc—Shock—Lisinopril—coronary artery disease	7.5e-05	0.000216	CcSEcCtD
Maraviroc—Asthenia—Perindopril—coronary artery disease	7.5e-05	0.000216	CcSEcCtD
Maraviroc—Vomiting—Niacin—coronary artery disease	7.49e-05	0.000216	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Timolol—coronary artery disease	7.49e-05	0.000216	CcSEcCtD
Maraviroc—Hypersensitivity—Furosemide—coronary artery disease	7.49e-05	0.000216	CcSEcCtD
Maraviroc—CCR5—Disease—PRKCD—coronary artery disease	7.48e-05	0.000378	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PLCB1—coronary artery disease	7.48e-05	0.000377	CbGpPWpGaD
Maraviroc—Dizziness—Trandolapril—coronary artery disease	7.45e-05	0.000215	CcSEcCtD
Maraviroc—Insomnia—Timolol—coronary artery disease	7.43e-05	0.000214	CcSEcCtD
Maraviroc—Rash—Niacin—coronary artery disease	7.43e-05	0.000214	CcSEcCtD
Maraviroc—Dermatitis—Niacin—coronary artery disease	7.42e-05	0.000214	CcSEcCtD
Maraviroc—Dizziness—Enalapril—coronary artery disease	7.42e-05	0.000214	CcSEcCtD
Maraviroc—Skin disorder—Lisinopril—coronary artery disease	7.41e-05	0.000213	CcSEcCtD
Maraviroc—Pruritus—Perindopril—coronary artery disease	7.4e-05	0.000213	CcSEcCtD
Maraviroc—Headache—Niacin—coronary artery disease	7.38e-05	0.000213	CcSEcCtD
Maraviroc—Paraesthesia—Timolol—coronary artery disease	7.38e-05	0.000212	CcSEcCtD
Maraviroc—Vomiting—Pravastatin—coronary artery disease	7.38e-05	0.000212	CcSEcCtD
Maraviroc—Diarrhoea—Captopril—coronary artery disease	7.37e-05	0.000212	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—HTR7—coronary artery disease	7.32e-05	0.000369	CbGpPWpGaD
Maraviroc—Dizziness—Telmisartan—coronary artery disease	7.32e-05	0.000211	CcSEcCtD
Maraviroc—Rash—Pravastatin—coronary artery disease	7.32e-05	0.000211	CcSEcCtD
Maraviroc—CCR5—Disease—MTHFR—coronary artery disease	7.31e-05	0.000369	CbGpPWpGaD
Maraviroc—Dermatitis—Pravastatin—coronary artery disease	7.31e-05	0.000211	CcSEcCtD
Maraviroc—Decreased appetite—Ramipril—coronary artery disease	7.31e-05	0.00021	CcSEcCtD
Maraviroc—Asthenia—Furosemide—coronary artery disease	7.29e-05	0.00021	CcSEcCtD
Maraviroc—Headache—Pravastatin—coronary artery disease	7.27e-05	0.000209	CcSEcCtD
Maraviroc—Anorexia—Lisinopril—coronary artery disease	7.27e-05	0.000209	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Ramipril—coronary artery disease	7.26e-05	0.000209	CcSEcCtD
Maraviroc—Fatigue—Ramipril—coronary artery disease	7.25e-05	0.000209	CcSEcCtD
Maraviroc—Hypersensitivity—Losartan—coronary artery disease	7.22e-05	0.000208	CcSEcCtD
Maraviroc—Nausea—Valsartan—coronary artery disease	7.2e-05	0.000207	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—GCLM—coronary artery disease	7.19e-05	0.000363	CbGpPWpGaD
Maraviroc—Pruritus—Furosemide—coronary artery disease	7.19e-05	0.000207	CcSEcCtD
Maraviroc—Constipation—Ramipril—coronary artery disease	7.19e-05	0.000207	CcSEcCtD
Maraviroc—Nausea—Olmesartan—coronary artery disease	7.17e-05	0.000206	CcSEcCtD
Maraviroc—Vomiting—Trandolapril—coronary artery disease	7.17e-05	0.000206	CcSEcCtD
Maraviroc—Diarrhoea—Perindopril—coronary artery disease	7.15e-05	0.000206	CcSEcCtD
Maraviroc—Decreased appetite—Timolol—coronary artery disease	7.14e-05	0.000206	CcSEcCtD
Maraviroc—Vomiting—Enalapril—coronary artery disease	7.14e-05	0.000205	CcSEcCtD
Maraviroc—Dizziness—Captopril—coronary artery disease	7.12e-05	0.000205	CcSEcCtD
Maraviroc—Rash—Trandolapril—coronary artery disease	7.11e-05	0.000205	CcSEcCtD
Maraviroc—Dermatitis—Trandolapril—coronary artery disease	7.1e-05	0.000204	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Timolol—coronary artery disease	7.1e-05	0.000204	CcSEcCtD
Maraviroc—Fatigue—Timolol—coronary artery disease	7.09e-05	0.000204	CcSEcCtD
Maraviroc—Rash—Enalapril—coronary artery disease	7.08e-05	0.000204	CcSEcCtD
Maraviroc—Dermatitis—Enalapril—coronary artery disease	7.07e-05	0.000204	CcSEcCtD
Maraviroc—Headache—Trandolapril—coronary artery disease	7.06e-05	0.000203	CcSEcCtD
Maraviroc—Vomiting—Telmisartan—coronary artery disease	7.04e-05	0.000203	CcSEcCtD
Maraviroc—Asthenia—Losartan—coronary artery disease	7.03e-05	0.000203	CcSEcCtD
Maraviroc—Headache—Enalapril—coronary artery disease	7.03e-05	0.000202	CcSEcCtD
Maraviroc—Pain—Timolol—coronary artery disease	7.03e-05	0.000202	CcSEcCtD
Maraviroc—Nausea—Niacin—coronary artery disease	7e-05	0.000202	CcSEcCtD
Maraviroc—Rash—Telmisartan—coronary artery disease	6.98e-05	0.000201	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ITGAV—coronary artery disease	6.98e-05	0.000352	CbGpPWpGaD
Maraviroc—CCR5—Disease—HIF1A—coronary artery disease	6.97e-05	0.000352	CbGpPWpGaD
Maraviroc—Dermatitis—Telmisartan—coronary artery disease	6.97e-05	0.000201	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—CYP11B2—coronary artery disease	6.97e-05	0.000351	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KNG1—coronary artery disease	6.96e-05	0.000351	CbGpPWpGaD
Maraviroc—Diarrhoea—Furosemide—coronary artery disease	6.95e-05	0.0002	CcSEcCtD
Maraviroc—Musculoskeletal discomfort—Lisinopril—coronary artery disease	6.95e-05	0.0002	CcSEcCtD
Maraviroc—Pruritus—Losartan—coronary artery disease	6.94e-05	0.0002	CcSEcCtD
Maraviroc—Headache—Telmisartan—coronary artery disease	6.94e-05	0.0002	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CREB1—coronary artery disease	6.93e-05	0.00035	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—POMC—coronary artery disease	6.93e-05	0.00035	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AGTR1—coronary artery disease	6.92e-05	0.000349	CbGpPWpGaD
Maraviroc—Dizziness—Perindopril—coronary artery disease	6.91e-05	0.000199	CcSEcCtD
Maraviroc—Insomnia—Lisinopril—coronary artery disease	6.9e-05	0.000199	CcSEcCtD
Maraviroc—Nausea—Pravastatin—coronary artery disease	6.89e-05	0.000198	CcSEcCtD
Maraviroc—Gastrointestinal pain—Ramipril—coronary artery disease	6.87e-05	0.000198	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP11B2—coronary artery disease	6.87e-05	0.000347	CbGpPWpGaD
Maraviroc—Paraesthesia—Lisinopril—coronary artery disease	6.85e-05	0.000197	CcSEcCtD
Maraviroc—Vomiting—Captopril—coronary artery disease	6.85e-05	0.000197	CcSEcCtD
Maraviroc—CCR5—Disease—APOE—coronary artery disease	6.81e-05	0.000343	CbGpPWpGaD
Maraviroc—Rash—Captopril—coronary artery disease	6.79e-05	0.000195	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CCL2—coronary artery disease	6.78e-05	0.000342	CbGpPWpGaD
Maraviroc—Dermatitis—Captopril—coronary artery disease	6.78e-05	0.000195	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—IL6R—coronary artery disease	6.76e-05	0.000341	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL10—coronary artery disease	6.76e-05	0.000341	CbGpPWpGaD
Maraviroc—Headache—Captopril—coronary artery disease	6.74e-05	0.000194	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PLG—coronary artery disease	6.74e-05	0.00034	CbGpPWpGaD
Maraviroc—CCR5—Disease—APOA1—coronary artery disease	6.73e-05	0.00034	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Timolol—coronary artery disease	6.72e-05	0.000194	CcSEcCtD
Maraviroc—Dizziness—Furosemide—coronary artery disease	6.72e-05	0.000193	CcSEcCtD
Maraviroc—Diarrhoea—Losartan—coronary artery disease	6.71e-05	0.000193	CcSEcCtD
Maraviroc—Nausea—Trandolapril—coronary artery disease	6.69e-05	0.000193	CcSEcCtD
Maraviroc—Nausea—Enalapril—coronary artery disease	6.67e-05	0.000192	CcSEcCtD
Maraviroc—Vomiting—Perindopril—coronary artery disease	6.65e-05	0.000191	CcSEcCtD
Maraviroc—Abdominal pain—Ramipril—coronary artery disease	6.65e-05	0.000191	CcSEcCtD
Maraviroc—Body temperature increased—Ramipril—coronary artery disease	6.65e-05	0.000191	CcSEcCtD
Maraviroc—Decreased appetite—Lisinopril—coronary artery disease	6.63e-05	0.000191	CcSEcCtD
Maraviroc—Rash—Perindopril—coronary artery disease	6.59e-05	0.00019	CcSEcCtD
Maraviroc—Dermatitis—Perindopril—coronary artery disease	6.58e-05	0.00019	CcSEcCtD
Maraviroc—Gastrointestinal disorder—Lisinopril—coronary artery disease	6.58e-05	0.00019	CcSEcCtD
Maraviroc—Nausea—Telmisartan—coronary artery disease	6.58e-05	0.000189	CcSEcCtD
Maraviroc—Fatigue—Lisinopril—coronary artery disease	6.57e-05	0.000189	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ADRB2—coronary artery disease	6.56e-05	0.000331	CbGpPWpGaD
Maraviroc—Headache—Perindopril—coronary artery disease	6.55e-05	0.000189	CcSEcCtD
Maraviroc—Constipation—Lisinopril—coronary artery disease	6.52e-05	0.000188	CcSEcCtD
Maraviroc—Pain—Lisinopril—coronary artery disease	6.52e-05	0.000188	CcSEcCtD
Maraviroc—Abdominal pain—Timolol—coronary artery disease	6.5e-05	0.000187	CcSEcCtD
Maraviroc—Body temperature increased—Timolol—coronary artery disease	6.5e-05	0.000187	CcSEcCtD
Maraviroc—Dizziness—Losartan—coronary artery disease	6.48e-05	0.000187	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PRKCE—coronary artery disease	6.48e-05	0.000327	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—JAK2—coronary artery disease	6.47e-05	0.000326	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SOCS1—coronary artery disease	6.46e-05	0.000326	CbGpPWpGaD
Maraviroc—Vomiting—Furosemide—coronary artery disease	6.46e-05	0.000186	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—S100B—coronary artery disease	6.44e-05	0.000325	CbGpPWpGaD
Maraviroc—Rash—Furosemide—coronary artery disease	6.41e-05	0.000184	CcSEcCtD
Maraviroc—Dermatitis—Furosemide—coronary artery disease	6.4e-05	0.000184	CcSEcCtD
Maraviroc—CCR5—Disease—IL6ST—coronary artery disease	6.4e-05	0.000323	CbGpPWpGaD
Maraviroc—Nausea—Captopril—coronary artery disease	6.39e-05	0.000184	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—SOCS3—coronary artery disease	6.38e-05	0.000322	CbGpPWpGaD
Maraviroc—Headache—Furosemide—coronary artery disease	6.37e-05	0.000183	CcSEcCtD
Maraviroc—CCR5—Disease—NOS2—coronary artery disease	6.34e-05	0.00032	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—SULT1A1—coronary artery disease	6.33e-05	0.000319	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GPX2—coronary artery disease	6.32e-05	0.000319	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KITLG—coronary artery disease	6.31e-05	0.000318	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TGFBR2—coronary artery disease	6.31e-05	0.000318	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GPX4—coronary artery disease	6.25e-05	0.000315	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—SULT1A1—coronary artery disease	6.25e-05	0.000315	CbGpPWpGaD
Maraviroc—Gastrointestinal pain—Lisinopril—coronary artery disease	6.23e-05	0.00018	CcSEcCtD
Maraviroc—Vomiting—Losartan—coronary artery disease	6.23e-05	0.000179	CcSEcCtD
Maraviroc—Nausea—Perindopril—coronary artery disease	6.21e-05	0.000179	CcSEcCtD
Maraviroc—Hypersensitivity—Ramipril—coronary artery disease	6.19e-05	0.000178	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—GSTA1—coronary artery disease	6.19e-05	0.000312	CbGpPWpGaD
Maraviroc—Rash—Losartan—coronary artery disease	6.18e-05	0.000178	CcSEcCtD
Maraviroc—Dermatitis—Losartan—coronary artery disease	6.18e-05	0.000178	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—MMP3—coronary artery disease	6.16e-05	0.000311	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—STAT5A—coronary artery disease	6.16e-05	0.000311	CbGpPWpGaD
Maraviroc—CCR5—Disease—KIT—coronary artery disease	6.14e-05	0.00031	CbGpPWpGaD
Maraviroc—Headache—Losartan—coronary artery disease	6.14e-05	0.000177	CcSEcCtD
Maraviroc—Hypersensitivity—Timolol—coronary artery disease	6.06e-05	0.000174	CcSEcCtD
Maraviroc—Nausea—Furosemide—coronary artery disease	6.04e-05	0.000174	CcSEcCtD
Maraviroc—Asthenia—Ramipril—coronary artery disease	6.03e-05	0.000174	CcSEcCtD
Maraviroc—Abdominal pain—Lisinopril—coronary artery disease	6.03e-05	0.000174	CcSEcCtD
Maraviroc—Body temperature increased—Lisinopril—coronary artery disease	6.03e-05	0.000174	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—APOB—coronary artery disease	5.96e-05	0.000301	CbGpPWpGaD
Maraviroc—Pruritus—Ramipril—coronary artery disease	5.95e-05	0.000171	CcSEcCtD
Maraviroc—CCR5—GPCR downstream signaling—CXCL8—coronary artery disease	5.91e-05	0.000298	CbGpPWpGaD
Maraviroc—CCR5—Disease—GSK3B—coronary artery disease	5.9e-05	0.000297	CbGpPWpGaD
Maraviroc—Asthenia—Timolol—coronary artery disease	5.9e-05	0.00017	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—JAK2—coronary artery disease	5.88e-05	0.000296	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—EDN1—coronary artery disease	5.86e-05	0.000296	CbGpPWpGaD
Maraviroc—CCR5—Disease—CREB1—coronary artery disease	5.85e-05	0.000295	CbGpPWpGaD
Maraviroc—Nausea—Losartan—coronary artery disease	5.82e-05	0.000168	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—CCL5—coronary artery disease	5.82e-05	0.000293	CbGpPWpGaD
Maraviroc—Pruritus—Timolol—coronary artery disease	5.81e-05	0.000167	CcSEcCtD
Maraviroc—Diarrhoea—Ramipril—coronary artery disease	5.75e-05	0.000166	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—FGF1—coronary artery disease	5.73e-05	0.000289	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CSF2—coronary artery disease	5.73e-05	0.000289	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6R—coronary artery disease	5.71e-05	0.000288	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LPL—coronary artery disease	5.69e-05	0.000287	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—RPS6KB1—coronary artery disease	5.64e-05	0.000284	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MEF2C—coronary artery disease	5.64e-05	0.000284	CbGpPWpGaD
Maraviroc—Diarrhoea—Timolol—coronary artery disease	5.62e-05	0.000162	CcSEcCtD
Maraviroc—Hypersensitivity—Lisinopril—coronary artery disease	5.62e-05	0.000162	CcSEcCtD
Maraviroc—Dizziness—Ramipril—coronary artery disease	5.56e-05	0.00016	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—ITGB3—coronary artery disease	5.49e-05	0.000277	CbGpPWpGaD
Maraviroc—Asthenia—Lisinopril—coronary artery disease	5.47e-05	0.000158	CcSEcCtD
Maraviroc—Dizziness—Timolol—coronary artery disease	5.43e-05	0.000156	CcSEcCtD
Maraviroc—Pruritus—Lisinopril—coronary artery disease	5.39e-05	0.000155	CcSEcCtD
Maraviroc—CCR5—Signaling by GPCR—CXCL8—coronary artery disease	5.36e-05	0.000271	CbGpPWpGaD
Maraviroc—Vomiting—Ramipril—coronary artery disease	5.35e-05	0.000154	CcSEcCtD
Maraviroc—CCR5—Disease—SERPINE1—coronary artery disease	5.34e-05	0.00027	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PPP2CA—coronary artery disease	5.34e-05	0.000269	CbGpPWpGaD
Maraviroc—Rash—Ramipril—coronary artery disease	5.3e-05	0.000153	CcSEcCtD
Maraviroc—Dermatitis—Ramipril—coronary artery disease	5.3e-05	0.000152	CcSEcCtD
Maraviroc—Headache—Ramipril—coronary artery disease	5.27e-05	0.000152	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—PRKCD—coronary artery disease	5.24e-05	0.000264	CbGpPWpGaD
Maraviroc—Vomiting—Timolol—coronary artery disease	5.23e-05	0.00015	CcSEcCtD
Maraviroc—Diarrhoea—Lisinopril—coronary artery disease	5.22e-05	0.00015	CcSEcCtD
Maraviroc—Rash—Timolol—coronary artery disease	5.18e-05	0.000149	CcSEcCtD
Maraviroc—Dermatitis—Timolol—coronary artery disease	5.18e-05	0.000149	CcSEcCtD
Maraviroc—CCR5—Disease—FGF2—coronary artery disease	5.17e-05	0.000261	CbGpPWpGaD
Maraviroc—Headache—Timolol—coronary artery disease	5.15e-05	0.000148	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—GPX3—coronary artery disease	5.13e-05	0.000259	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HTR2A—coronary artery disease	5.13e-05	0.000259	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—C3—coronary artery disease	5.12e-05	0.000258	CbGpPWpGaD
Maraviroc—CCR5—Disease—NOS3—coronary artery disease	5.1e-05	0.000257	CbGpPWpGaD
Maraviroc—Dizziness—Lisinopril—coronary artery disease	5.04e-05	0.000145	CcSEcCtD
Maraviroc—Nausea—Ramipril—coronary artery disease	4.99e-05	0.000144	CcSEcCtD
Maraviroc—CYP3A4—Biological oxidations—ALDH2—coronary artery disease	4.99e-05	0.000252	CbGpPWpGaD
Maraviroc—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—coronary artery disease	4.96e-05	0.00025	CbGpPWpGaD
Maraviroc—CCR5—Disease—JAK2—coronary artery disease	4.96e-05	0.00025	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—HIF1A—coronary artery disease	4.88e-05	0.000246	CbGpPWpGaD
Maraviroc—Nausea—Timolol—coronary artery disease	4.88e-05	0.000141	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—AGT—coronary artery disease	4.87e-05	0.000245	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—CYP2C19—coronary artery disease	4.86e-05	0.000245	CbGpPWpGaD
Maraviroc—Vomiting—Lisinopril—coronary artery disease	4.85e-05	0.00014	CcSEcCtD
Maraviroc—Rash—Lisinopril—coronary artery disease	4.81e-05	0.000138	CcSEcCtD
Maraviroc—Dermatitis—Lisinopril—coronary artery disease	4.8e-05	0.000138	CcSEcCtD
Maraviroc—CYP3A4—Metapathway biotransformation—CYP2C19—coronary artery disease	4.79e-05	0.000242	CbGpPWpGaD
Maraviroc—Headache—Lisinopril—coronary artery disease	4.78e-05	0.000138	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—APOE—coronary artery disease	4.77e-05	0.000241	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—LEP—coronary artery disease	4.77e-05	0.000241	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTT1—coronary artery disease	4.74e-05	0.000239	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—APOA1—coronary artery disease	4.71e-05	0.000238	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GCLC—coronary artery disease	4.69e-05	0.000236	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KDR—coronary artery disease	4.67e-05	0.000236	CbGpPWpGaD
Maraviroc—CCR5—Disease—PTGS2—coronary artery disease	4.67e-05	0.000235	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAPK14—coronary artery disease	4.64e-05	0.000234	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—ESR1—coronary artery disease	4.55e-05	0.00023	CbGpPWpGaD
Maraviroc—Nausea—Lisinopril—coronary artery disease	4.53e-05	0.00013	CcSEcCtD
Maraviroc—CCR5—Signaling Pathways—F2—coronary artery disease	4.5e-05	0.000227	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FN1—coronary artery disease	4.5e-05	0.000227	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6ST—coronary artery disease	4.48e-05	0.000226	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NFKBIA—coronary artery disease	4.44e-05	0.000224	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—KIT—coronary artery disease	4.3e-05	0.000217	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—GSK3B—coronary artery disease	4.13e-05	0.000208	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—POMC—coronary artery disease	4.1e-05	0.000207	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CREB1—coronary artery disease	4.1e-05	0.000207	CbGpPWpGaD
Maraviroc—CYP3A4—Phase 1 - Functionalization of compounds—POMC—coronary artery disease	4.02e-05	0.000203	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCL2—coronary artery disease	4.01e-05	0.000202	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6R—coronary artery disease	4e-05	0.000202	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IGF1—coronary artery disease	3.94e-05	0.000199	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—MAPK1—coronary artery disease	3.92e-05	0.000198	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—PIK3CA—coronary artery disease	3.75e-05	0.000189	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—SERPINE1—coronary artery disease	3.74e-05	0.000189	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GGT1—coronary artery disease	3.66e-05	0.000185	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—FGF2—coronary artery disease	3.62e-05	0.000183	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—NOS3—coronary artery disease	3.57e-05	0.00018	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—JAK2—coronary artery disease	3.47e-05	0.000175	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—PIK3CA—coronary artery disease	3.4e-05	0.000172	CbGpPWpGaD
Maraviroc—CCR5—Disease—TGFB1—coronary artery disease	3.37e-05	0.00017	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CA5B—coronary artery disease	3.32e-05	0.000168	CbGpPWpGaD
Maraviroc—CCR5—Disease—MAPK1—coronary artery disease	3.31e-05	0.000167	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTP1—coronary artery disease	3.29e-05	0.000166	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTP1—coronary artery disease	3.24e-05	0.000164	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CXCL8—coronary artery disease	3.17e-05	0.00016	CbGpPWpGaD
Maraviroc—CCR5—GPCR downstream signaling—AKT1—coronary artery disease	3.06e-05	0.000154	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CASP3—coronary artery disease	3.03e-05	0.000153	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—GSTM1—coronary artery disease	3.02e-05	0.000152	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—IL6—coronary artery disease	3.01e-05	0.000152	CbGpPWpGaD
Maraviroc—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	2.98e-05	0.00015	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—CCND1—coronary artery disease	2.95e-05	0.000149	CbGpPWpGaD
Maraviroc—CCR5—Disease—PIK3CA—coronary artery disease	2.87e-05	0.000145	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MMP9—coronary artery disease	2.87e-05	0.000145	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CKMT1B—coronary artery disease	2.83e-05	0.000143	CbGpPWpGaD
Maraviroc—CCR5—Signaling by GPCR—AKT1—coronary artery disease	2.78e-05	0.00014	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—VEGFA—coronary artery disease	2.57e-05	0.00013	CbGpPWpGaD
Maraviroc—CCR5—Disease—IL6—coronary artery disease	2.54e-05	0.000128	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—TGFB1—coronary artery disease	2.36e-05	0.000119	CbGpPWpGaD
Maraviroc—CCR5—Disease—AKT1—coronary artery disease	2.34e-05	0.000118	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—MAPK1—coronary artery disease	2.32e-05	0.000117	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPAP2B—coronary artery disease	2.3e-05	0.000116	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CKM—coronary artery disease	2.3e-05	0.000116	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	2.3e-05	0.000116	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PYGM—coronary artery disease	2.14e-05	0.000108	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SULT4A1—coronary artery disease	2.14e-05	0.000108	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PDK4—coronary artery disease	2.14e-05	0.000108	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	2.14e-05	0.000108	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CKMT2—coronary artery disease	2.14e-05	0.000108	CbGpPWpGaD
Maraviroc—CYP3A4—Biological oxidations—POMC—coronary artery disease	2.13e-05	0.000108	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—PIK3CA—coronary artery disease	2.01e-05	0.000101	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LDHA—coronary artery disease	1.91e-05	9.63e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GK—coronary artery disease	1.91e-05	9.63e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMGCS2—coronary artery disease	1.91e-05	9.63e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PFKM—coronary artery disease	1.91e-05	9.63e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GYG1—coronary artery disease	1.91e-05	9.63e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GATM—coronary artery disease	1.91e-05	9.63e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCH1—coronary artery disease	1.82e-05	9.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AK1—coronary artery disease	1.82e-05	9.19e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—IL6—coronary artery disease	1.78e-05	8.98e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—UGCG—coronary artery disease	1.75e-05	8.81e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPAT—coronary artery disease	1.75e-05	8.81e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLCD1—coronary artery disease	1.75e-05	8.81e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MDH2—coronary artery disease	1.75e-05	8.81e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PGM1—coronary artery disease	1.68e-05	8.48e-05	CbGpPWpGaD
Maraviroc—CCR5—Signaling Pathways—AKT1—coronary artery disease	1.64e-05	8.28e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PYGB—coronary artery disease	1.62e-05	8.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CKB—coronary artery disease	1.62e-05	8.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLIN1—coronary artery disease	1.53e-05	7.7e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTM2—coronary artery disease	1.53e-05	7.7e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DLAT—coronary artery disease	1.53e-05	7.7e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—COX5B—coronary artery disease	1.53e-05	7.7e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PFKFB3—coronary artery disease	1.53e-05	7.7e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SULT1E1—coronary artery disease	1.45e-05	7.3e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AKR1B1—coronary artery disease	1.38e-05	6.96e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HK2—coronary artery disease	1.38e-05	6.96e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC27A1—coronary artery disease	1.32e-05	6.67e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CPT1B—coronary artery disease	1.3e-05	6.55e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LCAT—coronary artery disease	1.3e-05	6.55e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOA4—coronary artery disease	1.27e-05	6.42e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PDHA1—coronary artery disease	1.23e-05	6.21e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCLM—coronary artery disease	1.23e-05	6.21e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—TXNRD1—coronary artery disease	1.19e-05	6.01e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP11B2—coronary artery disease	1.19e-05	6.01e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC22A3—coronary artery disease	1.17e-05	5.92e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HADH—coronary artery disease	1.16e-05	5.83e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ARNTL—coronary artery disease	1.16e-05	5.83e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOA2—coronary artery disease	1.1e-05	5.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	1.1e-05	5.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GPX2—coronary artery disease	1.1e-05	5.53e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HK1—coronary artery disease	1.08e-05	5.46e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GPX4—coronary artery disease	1.08e-05	5.46e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ABCG5—coronary artery disease	1.08e-05	5.46e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SULT1A1—coronary artery disease	1.08e-05	5.46e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HADHA—coronary artery disease	1.07e-05	5.4e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTA1—coronary artery disease	1.06e-05	5.34e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LPA—coronary artery disease	1.05e-05	5.28e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLCB3—coronary artery disease	1.01e-05	5.11e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOA5—coronary artery disease	1e-05	5.06e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—P4HB—coronary artery disease	9.83e-06	4.96e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	9.65e-06	4.87e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—VCAN—coronary artery disease	9.1e-06	4.59e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDOA—coronary artery disease	9.03e-06	4.55e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—DCN—coronary artery disease	8.76e-06	4.42e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALDH2—coronary artery disease	8.53e-06	4.3e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CYP2C19—coronary artery disease	8.31e-06	4.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HBA1—coronary artery disease	8.31e-06	4.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	8.31e-06	4.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LIPC—coronary artery disease	8.31e-06	4.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOC3—coronary artery disease	8.26e-06	4.17e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LDLR—coronary artery disease	8.21e-06	4.14e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SLC9A1—coronary artery disease	8.11e-06	4.09e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTT1—coronary artery disease	8.11e-06	4.09e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CETP—coronary artery disease	8.02e-06	4.04e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GCLC—coronary artery disease	8.02e-06	4.04e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—SDC1—coronary artery disease	7.93e-06	4e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PSMB5—coronary artery disease	7.49e-06	3.78e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PSMA6—coronary artery disease	7.49e-06	3.78e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CTGF—coronary artery disease	7.32e-06	3.69e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT2—coronary artery disease	7.25e-06	3.66e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMGCR—coronary artery disease	7.25e-06	3.66e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PLCB1—coronary artery disease	6.67e-06	3.36e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ABCA1—coronary artery disease	6.46e-06	3.26e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GGT1—coronary artery disease	6.26e-06	3.16e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GOT1—coronary artery disease	6.26e-06	3.16e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTP1—coronary artery disease	5.62e-06	2.84e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	5.57e-06	2.81e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—HMOX1—coronary artery disease	5.54e-06	2.8e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CAT—coronary artery disease	5.47e-06	2.76e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOB—coronary artery disease	5.31e-06	2.68e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GSTM1—coronary artery disease	5.17e-06	2.61e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—LPL—coronary artery disease	5.07e-06	2.56e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—GPX1—coronary artery disease	4.95e-06	2.5e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—CD36—coronary artery disease	4.82e-06	2.43e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPP2CA—coronary artery disease	4.76e-06	2.4e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—MTHFR—coronary artery disease	4.57e-06	2.3e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AGT—coronary artery disease	4.34e-06	2.19e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOE—coronary artery disease	4.25e-06	2.14e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—APOA1—coronary artery disease	4.2e-06	2.12e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PPARG—coronary artery disease	3.7e-06	1.87e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—POMC—coronary artery disease	3.65e-06	1.84e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—ALB—coronary artery disease	3.33e-06	1.68e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—NOS3—coronary artery disease	3.18e-06	1.61e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PTGS2—coronary artery disease	2.91e-06	1.47e-05	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—PIK3CA—coronary artery disease	1.79e-06	9.04e-06	CbGpPWpGaD
Maraviroc—CYP3A4—Metabolism—AKT1—coronary artery disease	1.46e-06	7.38e-06	CbGpPWpGaD
